Acticlate CAP 75 mg/1 (Doxycycline Hyclate CAPSULE) 75 mg/1

Acticlate CAP 75 mg/1 is a doxycycline hyclate capsule used for various bacterial infections. This oral medication is manufactured by Aqua Pharmaceuticals in the USA.

Strength

75 mg/1

Pack Size

60 CAPSULE in 1 BOTTLE (16110-601-01)

Manufacturer / TM Owner

Aqua Pharmaceuticals

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Acticlate CAP 75 mg/1 is commonly used to treat bacterial infections, including respiratory, urinary tract, and skin infections. It is also used for what is doxycycline hyclate used for in managing certain sexually transmitted diseases and acne. This broad-spectrum antibiotic works by stopping the growth of bacteria.

Side Effects

Common effects of Acticlate CAP 75 mg/1 may include nausea, diarrhea, and skin sensitivity to sunlight. Some users might experience mild stomach upset or loss of appetite. These effects are generally temporary and may vary among individuals.

Precautions & Warnings

Handle Acticlate CAP 75 mg/1 with care, storing it at room temperature away from moisture and heat. Take the capsule with a full glass of water to avoid irritation. Avoid taking it with dairy products or antacids, as they can reduce its effectiveness.

Avoid Interactions

Acticlate CAP 75 mg/1 may interact with certain medications, including antacids, blood thinners, and other antibiotics. It is advisable to consult a healthcare provider before combining it with other treatments. Alcohol should be avoided as it may increase the risk of side effects.

Frequently Asked Questions

Acticlate CAP 75 mg/1 is used to treat various bacterial infections, including respiratory, urinary tract, and skin infections, as well as certain sexually transmitted diseases and acne.

Store Acticlate CAP 75 mg/1 at room temperature, away from moisture and heat. Keep the bottle tightly closed and out of reach of children.

It is recommended to avoid taking Acticlate CAP 75 mg/1 with dairy products or antacids, as they can reduce the medication's effectiveness.

Common side effects may include nausea, diarrhea, and skin sensitivity to sunlight. These effects are usually mild and temporary.

It is advisable to avoid alcohol while taking Acticlate CAP 75 mg/1, as it may increase the risk of side effects.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.